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In·1929 Marrian (45) isolated, from pregnancy urine, a steroid 
alcohol devoid of progeste.tional activity. A year later this compound 
was identified and named pregnanediol by Butenandt ( 13). Subsequent to 
the isolation and crystallization of progesterone in the early 1930's 
(2,25,26), the two substE'.nces were shown to be stru<:turally similar, and it 
was proposed that Marritl.n' s inactive steroid might he a metE.bolic product 
of the corpus luteum hormone. 
Since that time it has been postulated by mruty workers that there 
are three main classes of metabolic reduction produuts of progesterone: 
1) pregnanediones, 2) pregnanolones, and 3} pregnan,~iols (Figure 1). 
Among these it has been further shown that 58-pregnane Ja, 20a-diol 
(pregnanediol) is the urinary metabolite found in g::-eetest quantity in 
both normal pregnant and normal non-pregnant women (22,42-44,69). 
In 1936, working with pregnancy urine, Venning and Browne were able 
to demonstrate that pregnanediol was present in the urine in the form of a 
wa.ter soluble conjugate with sodium glucuronidate (:ITaPG) (73). This work 
was extended in 1937 to include recoveries of NaPG during the luteal phase 
in normal menstrual urines (75), and subsequently b:r many investigators to 
the recovery of NaPG from the urine after the parenteral administration of 
progesterone (14,55,59,60). 
It may be logically ste.ted, therefore, that pregnanediol excreted 
in the urine is a reflection of progesterone secretion wherever it occurs. 
SOURCES OF PROGESTERONE 
1. Ovarz. 
There is excellent evidence that progesterone is produced in the 
ovary, and that the site of primary synthetic activ:Lty is the theca-lutein 
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cell (50,51). Numerous investigators have lent indirect support to this 
hypothesis by demonstrr-.ting a sharp rise in urinary pregnanediol during 
the ascendancy of the corpus luteum following ovulet:.on (9,10,18,28,32, 
37,40,64,74,79,80). 
2. Adrenal. 
Direct evidence for the synthesis of progeste:~ne in adrenal tissue 
is meager. Beall isolated the steroid from ox adrenal in 1938 (7), and 
Hoffman was successful with human fetal adrenals in 1947 (34). However 
abundant indirect evidence of adrensl progesterone a~~tivity has come from 
the studies of Klapper, et al (39,40), who have show:1. that pregnanediol is 
excreted in low quantities (of the order of 0.60 - 1.50 mg/24 hrs) in the 
urine of men, post-menopausal women, ~nd women in the pre-ovulatory phase 
of a normal cycle. Other investigators, notably Engel, have confirmed this 
evidence (23). Although one dase has been reported oy Klapper (40), as far 
as is known, no complete studies on castr~te females have been reported 
to date. 
3. Plactenta. 
The third source of progesterone is the placenta for which good 
direct evidence of synthetic activity exists (21,49,56). The considerable 
amounts of pregnanediol found in the urine during pregnancy imflicate the 
placenta and are well documented (12,71). 
METHODS 
Pregnanediol, lacking biologic activity, is test determined by 
chemical assay. Loraine (44) has usefully clessified the chemical methods 
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into two main groups: 1) Those in which pregnanediol is estimated in its 
conjugated form as sodium pregnanediol glueuronidate (NaPG), and 2) Those in 
which the glucosiduronate is first hydrolzed either by acid or enzymes, and 
then determined in its free stete by precipitation cr by chromatogre.phic 
methods. 
1. Determination of sodium pregnanediol glucuronidete. 
Venning, in 1937, was the first to publish a method for estimeting 
the pregnanediol in urine ( 71, 72). Her method consi. sted in the extraction 
of the urine with butanol, precipite.tion with acetone, drying, and gravi-
metric determination of the resultant residue, which was assumed to be 
chiefly NaPG. Following this importa.nt work the Verming method was utilized 
successfully by many investigators. Much of the ea1·ly work relating preg-
nanediol with the placenta was carried out applying this technique to 
pregnancy urines. 
Despite numerous methodologic modifications of this technique (1,8,48), 
including those in which the glucosiduronic acid frnction, instead of the 
steroid fraction, was determined, there arose cert~:.n obj eetions e.mong which 
the following have remained valid: 1) Falsely low readings were obtained 
when the urine was not properly preserved and ba.ctel'ial action hydrolyzed 
some of the NaPG, 2) Falsely high readings were obtnined because other 
glucosiduronate conjugated steroids were present along with the NaPG. This 
ls.ck of specific! ty we.s demonstrated by Ma.rrian and Sutherland when they were 
able to identify 20 percent of the Venning residue :Ln pregnancy urines as 
pregnanolone glucosiduronate (46,65). These object:lons assume greater im-
portance when dealing with the very small quanti tie,:; of pregnanediol present 
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in urine from pre-ovulatory, non-pregnant females. 
2. Determination of pregnanediol from hydrolyzed NePG. 
a. Acid hydrolysis - precipitation methods. 
Astwood end Jones in 1941 (4), attempted to cvercome some of the 
objectionable features of the Venning technique and introduced a method lhich 
measured "free" pregnanediol after acid hydrolysis c f the glycoside linkage. 
In brief, the method encompassed hydrolysis with boiling HCl, toluene ex-
traction, neutralization with NaOH, repeated precipitations of the "free" 
pregnanediol from alcoholic solution, drying, and gt·avimetric determination. 
The accure.cy of the method, reported by some workere. to be as low as 43 percent 
in control studies (53), was improved by Talbot, et al who determined the 
amount of steroid present by colorimetric measuremer.t of the sul!h uric acid 
chromogens of the "free" pregnanediol (66}. 
The ability of pregnanediol to produce a color, when acted upon by 
sulphuric acid, has been used most extensively in subsequent methods of preg-
nanediol assay. This color reaction is non-specifi,:, so the purity of the 
pregnanediol obtained in the final step of any meth,,d is of paramount impor-
tance. Numerous attempts to improve the purity of the end product in the 
Astwood-Talbot procedure have been made. Most of these trave been only partial-
ly successful, but have fallen short of the necessar'Y aim of quanti te.tive 
recovery from control experiments. In this respect:. Sommerville was probably 
the most successful (62). In general these modificr..tions of the basic Astwood-
technique have entailed only mmnor variations of p~,cedure and have not 
altered the basic method (3,20,24,29,31,35,57,61,62,68). 
The chief objection to the Astwood-Talbot me·:llod, involving precipi-
tation for purifice.tion, has been its inability to distinguish the presense 
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of non-specific (usually steroid) chromogens carriec through the precipi-
tations to the final colaimetric measurement. ThesE chromogens have been 
responsible for the recording of falsely high valueE: for pregnanediol, and 
have masked the determination of very minute amountf: of this metabolite. 
b. Acid hydrolysis - chromatographic methodr~. 
Because the accuracy of any technique dependu upon the purity of 
the final product, de Watteville, et al, in 1948, Ulling the basic Astwood-
Talbot method, introduced alumina column chroma.togrhphy of the neutral 
steroid fraction (78). Other workers utilized theiJ• technique with minor 
modifications, and were able to report good control recoveries and greater 
sensitivity than with precipitation methods (36,52,1)3). 
Perhaps the most exhaustive examination of ~1e single column 
chromatography method was reported by Verboom in 19~57 (76). He critically 
analyzed each step in the process, and found that the temperature and time 
were critical factors in optimal acid hydrolysis ancl in the color react!.. on 
with sulphuric acid. 
In 1955 Klapper, Michie, and Brown introduced a double alumina 
column chromatographic method, which has subsequently proven to be the most 
sensitive technique involving acid hydrolysis (39). Essentially, the method 
is one of hot acid hydrolysis of a urine aliquot, tJluene extraction, 
permanganate oxidation to remove a chromogenic steroid contaminant believed 
to be a break-down product of pregnanetriol, chromatography, acetylation to 
pregnanediol diacetate, furtl1er chromatography, and colorimetric determination 
after reaction with sulphuric acid. The authors wer-e able to state, after 
infra-red spectroscopic examination of the end product, that it contained 
virtually pure 5B-pregnane 3a, 2Cil.-diol. Control rt~coveries of over 90 percent 
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of added steroid, attest to the sensitivity of the technique. The reliability 
and sensitivity of the method was confirmed in an exhaustive study by Coyle, 
Mitchell, and Russell in 1956 (19). Jensen, using essentially the same method, 
introduced a correction factor designed to nullify the effect of residuel 
non-specific chromogens on the extinction coefficient (37). He reported 
83 to 99 percent recoveries on samples containing only 0.01 mg of steroid. 
This correction factor was based on the observvtion that the maximum absorp-
tion of pregnanediol diacetate occurs at a wavelength of 415 mu, and that the 
non-specific chromogenic material alone absorbed ma~imally at about 530 mu. 
This factor was then the ra.tio E530/E415. 
c. Enz:rme hydrol:£sis. 
The principle of enzyme hydrolysis of conjugt:ted steroids (estrogens) 
was first described by Cohen and Marrian in 1935. ~'hese workers, utilizing 
bacterial action on pregnancy urine, were subsequen1.ly able to implicate 
beta-glucuronidast'fl as importH-nt components of the hydrolysis reaction (17). 
Fishman in 1939 (27), Talbot and co-workers in 1943 (67), and Mason &nd 
Kepler in 1945 (47) all demonstrated the ability of animal tissue beta-glu-
curonidase preparations to hydrolyze various Cl9 and C21 steroid glucosid-
uronates. In 1951 Cohen studied the effect of calf spleen glucuronidase on 
the hydrolysis of many urinary steroid glucosiduronates including NaPG (15). 
He reported the interesting observation that NaPG iB enzymatically hydrolyzed 
approximately twenty times faster than are the urinary conjugates of the 
corticosteroids, ketosteroids, or of estriol. Although determining only the 
glucosiduronic acid fraction after hydrolysis in th:~s study, Cohen and 
Goldfine later (to) used beta-glucuronidase hydroly::~is coupled with Sommerville's 
purification system (62) to isolate pregnanediol. In this latter investi-
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gation sensitivities of 0.04 mg of pregnanediol were obtained, and the 
authors concluded th s.t the relatively short incubE. ticm time and low 
concentration of the enzyme required to cleave the glycoside linkage of 
NaPG made the method specific for this steroid. Thefle same workers later 
compared various glucuronidase preparations and found that e commercial 
preparation of beef liver beta-glucuronidase had the greatest sensitivity, 
enabling them to recover 100 percent of added steroid from controls (16) 
It was not noted whether or not the final product of these determinations 
was characterized to be identical to the control pregnanediol. 
Bongiovanni in 195.3 (9) utilizing the method of MarriE_n and Sommerville 
(61) recoered both pregnanediol and pregnanetriol fr<>m the urine of patients 
with adrenal hyperplasia, and concluded that the preBense of the latter 
steroid in some way influenced the measurement of pr·:Jgnanediol. This inter-
ference phenomenon was further investigated by Bongiovanni am Clayton (10) 
in a continuation of their study of steroid excretio:1 in adrenal hyperplasir.. 
The authors compared recoveries of the two progester•me metabolites using both 
acid end enzyme hydrolysis. They found thRt pure pr?-gnanetriol, submitted to 
acid hydrolysis, was not eluted in the expected fraction, and indeed, when 
this me.terial was examined by infra-red absorption s~ctroscopy, it wss found 
to be no longer the original steroid. This unknown steroid was eluted off the 
column with the pregnanediol fraction, a.nd reacted ·Ni th sulphuric eci.d to 
produce the same color reflction as this metabolite. 
In order to avoid these artifacts introduced oy acid hydrolysis, the 
authors selected a process, which combined the excellent purification of double 
ciiumn chromatography with the specificity of enzymatic hydrolysis. A simple 
three fraction elution using ethanol in benzene was employed yielding excellent 
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recoveries of pregnanetriol. Although briefly die.cu:>sing the va.lue of their 
method for determining urinary pregnanediol, these workers were primarily 
interested in the pregnanetriol fraction. 
Ronan, Parsons, Namiot, aad Wotiz have recent:Ly used a modification 
of the Bongiovanni technique for the measurement of pregnmetriol during 
pregnancy. In their report of this study (54) they observed the interesting 
fact that increasing concentrations of the enzyme re:mlted in decreasing 
recoveries of the free steroid, and found that grestHr recoveries were 
obtain~ using 1/lOth of the amount of beta-glucuron:.dase preparation used 
by Bongiovanni. Wotiz e~d Ronan (80) have used this same technique success-
fully in this laboratory for the recovery of pregne.rwdiol, and consistently, 
have been able to reproduce sensitivities of the ordElr of 0.02 mg/150 cc. 
aliquot of urine. The determination of pregnanediol in the urines of three 
castrate women reported herein was done using this l~~tter technique. 
PR1GNANEDIOL EXCRl!."l'ION DURING THE MENS~'RUAL CYCL!!: 
That there is a sharp rise in the urinary levd of pregnanediol 
during the so-cc-dled luteal phase of the normal menstrual cycle is well 
documented (9,10,18,28,32,37 ,40,64, 74, 79,80). ValueE: ranging as high as 
15.0 mg/24 hrs. have been reported in the post-ovulatory phase of nor~~Rl 
cycles. 
Most recent publications have reported the prf1-ovulatory va.lues of 
pregnanediol to be of the order of 0.75 - 1.50 mg/24 hrs., and showed them 
to have no tendency to rise or fall significently until one to two days after 
ovulation is believed to occured and the corpus luteu.m has become functional. 
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(In general ovulition was measured either by basal temperature curves or 
endometrie.l biopsy.) Earlier workers were unable to detect aey pregnanediol 
in the proliferative phase (74-77). Recently Wotiz aad co-workers have been 
able to demonstrete a significant level in the pre-o~ilatory phase of fifteen 
normal women. Ovulation was determined primarily by 9lectrovaginal potenti~l, 
and occasionally also by basal temperature curves and endometrie.l biopsy (80). 
Evidence of relatively flat, low, pregnanediol excretlon curves persisting 
throughout a cycle, determined to be anovulatory by eJldometrial biopsy, was 
reported by Klapper (41), and has been observed by Wotiz, et a1 in this 
laboratory. (Figure 2.) Low, non-fluctuating values of pregnanediol, averaging 
0.60:t 0.22 mg/24 hrs. have been observed in post-menopausal women (40). 
All of these observEtions serve to confirm the role of the corpus 
luteum in the formation of progesterone. This has long been accepted by both 
biologists e.nd elinicians. Less widely accepted, howover, have been the 
recent obserVations of a low level of progesterone prosent throughout the 
cycle, a.s reflected by urinary pregnanediol levels. Contrary then to the 
generally held clinical view, there is no time during the normal or anovulatory 
cycle when progesterone is completely absent. Reasonu to susvect this finding 
on a physiologic basis will be expanded upon. 
If one acce.t=ts the ovary a.s the major source of progesterone, and the 
adrenal as the only other important source in the non--pregnant 10 man, then one 
rust conclude that these low levels of pre-ovulatory pregnanediol reflect a 
sort of baseline activity attributable to either one or both of these organs. 
Evidence supporting the adrenal as a source of progesterone has been 
presented (2.3,.39,40). A st8tistical analysis of Klapper's data. (40), (ten 
women in the proliferative phase, average: l.O:t 0.10 ug/24 hrs, and ten post-
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menopausal women, averFge: 0.60.:t: 0.22 mg/24 hrs.) shoNs there to be 
significantly greater (P< .01) amounts of pregnanediol in the urines of the 
pre-ovulatory women tha.n in the urine of women past m:mopause. This tends 
strogly to confirm the adrenal contribution. We are well aware that many 
physiologic and endocrinologic differences exist betwt~en the pre-menopaus6l 
and post menopausal woman, and that these alone may ar:count for the disparity 
in pregnanediol excretion. However it is felt that in the absense of more 
definitive experimental work, this comparison is evidEmce in support of, not 
only an adreanl role, but a lesser ovarb.n one as well. Urinary pregnanediol 
excretion in one women before and after bilateral oophorectomy in Klapper's 
series, showed there to be a rise above, and then a fell below, the pre-
operative levels, which further tends to confirm this dual organ contribution, 
~:nd perhaps in addition, implicates the stress reacticn on pregnanediol recover-
ies. In a small pilQt study we have found an average level of 1.1 mg/24 hrs. 
in three women on whom bilateral oophorecto~ was performed three to five years 
previously. Indication for surgery in all three cases was either mammary or 
uterine maligaancy, and no pre-operative pregnanediol values were available. 
tndividual values are reported in Table I. A larger, well controlled study 
a: this nature seems worthy of further investigation, and is e.t present in 
progpess. 
It seems probable, on the basis of the foregoin; evidence, that there 
is an ovarian contribution to this pre-ovulatory pregnanediol level. However 
experimental evidence for this hypothesis is inadequat•? at present. In fact 
Klapper's demonstration of a decrease to barely detectHble levels {average: 
0.23 mg/24 hrs.} following bilateral adrenalectomy in 1romen previously oophor-
ectomized for recurrmt or metastetic carcinoma of the brea.st possibly suggest 
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still other sources of progesterone which, in the normal woman, contribute 
only miDimal amounts of the steroid. In regard to these patients, as well 
as the three patients in our small pilot study, it miy be well to remember 
the possible interrelationship that this particular neoplasm has with steroid 
metEbolism, arrl to be cautious in drawing the parE,llt~l to the normal sit-
uation. 
Loraine, in his excellent review of the subject, indicated that the 
generslly observed value of approximately 1.0 mg/24 hrs. for the follicular 
phase i~ "presumably representative of mainly adrenal pregnanediol" (44). 
This seems not to preclude a siD8.ll.er, but definitely me11sureable, ovs.rian 
contribution. The enzyme systems present in the ovar,r, and responsible for 
progestecne synthesis, are capable of different rates of biosynthetic activity, 
and are undoubtedly controlled by extrinsic factors, one of the most importE,nt 
of which ie the anterior pi tui tery. The central role of fr ogesterone in 
steroidogenisis, as elucidated by the exhaustive work particularly of the 
group at the Worcester Foundation (33), and indicated in Figure 4., dictates 
the necessity of its continuing presence, not only in the adrenal, where its 
metabolism appears necessary for the s,ynthesis of the eorticosteroids, androgens, 
and estrogens, but also in the ovary where its key role in estrogenisis assumes 
grea.test import~.nce. Viewing this ove.rb.n pool as a s:l te of dynamic endocrine 
metabolic activity, it seems inconceiva.ble that at any time there could be a 
zero rate of progesterone synthesis, and equally unliknly that the total 
circulating blood level of this steBDid could fall to 2wro. Many workers have 
shown that there is a peak of estrogen activity occurring at the time of 
ovulation (lli).. It is suggested then that, with ovul&tion and the possible 
increased requirement for estrogen, as evidenced by the excretion peak, there 
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is a relatively greater direction of the available progesterone into the 
estrogenic pathway, and that this is reflected in a d~op in the urinary 
excretion of pregnanediol to near "zero" values. In this labor&tory, Wotiz 
has been able to demonstrate this ovulatory drop in S•3Veral normal females. 
A typical excretion curve for one of these women is shown 1n Figure 3. 
It may then be postulated that throughout the normal menstrual cycle 
the~ are two, unequal, superimposed, "baselines" of pregne.nediol excretion. 
The quantitatively greater component of the baseline f•robably represents the 
adrenal contribution, In the absense of stress, it is likely rP.letively 
consts.nt throughout the cycle, and is regulated by the anterior pituitary 
gland. The lesser component arises from the ovary during the pre-luteal 
phase, and may well be regulated by the pitui te.ry gonadotropins and/or by 
the requirements for estrogens. The ovarian contribut:Lon to progesterone 
forma.tion in the luteal phase becomes of course ma.ny t:Lmes that of the 
adrenal cortex, and may represent the endometrial need for great quantities 
of the _progestc.tional hormone i t.self. The return of pregnanediol levels 
to "zero" just prior to the onset of menstruation, as I'eported by earlier 
workers in this field, may actually represent a return to this adrenal-
ovs.rian dual baseline, the detection of which has had to await the advent 
of more sensitive techniques for the determination of tne metabolite in 
urine. 
SUMMARY 
1. A review of the methods for the determination of pregnanediol in urine 
has been presented. 
2. A comparison of these techniques from the standlX>in·:.s of relinbility, 
sensitivity, and applicability to various clinical situations has been 
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attempted. 
,3. Existance of significant amounts of pregnanediol in the urine during 
the pre-corpus luteum phase of the normal menstrual j:ycle, a fact not widely 
accepted from the clinical viewpoint, has been sugge:lted. 
4. Measureable levels of pregnanediol have been demonstre.ted in castrate 
females. 
5. Some possible explane.tions as to the biosynthetic activity responsible 
for pre-ovulatory pregnanediol levels, and the sharp decrease in these levels 
at ovulation are proposed. 
I. 
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Figure 1. 
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Figure 2. 
DAILY PREGNANEDIOL EXCRETION I 1URING 
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Figure 4. 
DIAGRAMMATIC PATHWAY OF STEROIDOGENISIS 
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Table I. 
URINARY PREGNANEDIOL IN 3 PATIENTS AFTEF. 
BILATERAL OOPHORECTOMY 
Pregnanediol 
Patient post-oophorecto~ mg/24 hrs. 
L.S. 
M.K. 
A.S. 
72 
30 
58 
0.90 
1.10 
1.30 
~~~~------~--------------------------~ 
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